“Qualitest Recalls Allopurinol Tablets Due to Defects.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44007-qualitest-pharmaceuticals-recalls-allopurinol-tablets-usp-300-mg-500-count. Based on FDA recall #D-1405-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1405-2015%22&limit=1).
The FDA announced on July 20, 2015, that Qualitest Pharmaceuticals voluntarily recalled Allopurinol Tablets USP 300 mg due to failed tablet specifications involving oversized and discolored tablets. The recall affects 21,552 units distributed nationwide and in Puerto Rico.
How to tell if you have it
Brand: Qualitest Pharmaceuticals
Product: Allopurinol Tablets USP 300 mg
NDC: 0603-2116-28
Lot code: CP0761501
Expiration date: 12/16
The hazard
The tablets failed specifications for size and appearance, with reports of oversized and discolored tablets. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Qualitest Pharmaceuticals has 12 other recalls on record since April 19, 2013. Other recent recalls include Hydroxyzine Tablets due to unreadable codes on June 29, 2015, Disulfiram 500mg Tablets due to dissolution failure on June 18, 2015, and Promethazine VC with Codeine Syrup due to impurity issues on March 25, 2015. Other recent recalls of similar products include Shoolin Pharma Chem Sildenafil Recall: FDA Inspection Findings (August 3, 2026), Golden State Medical Recalls Prasugrel HCl 10mg Tablets (August 21, 2026), and Inventia Chlorthalidone Recall: Failed Dissolution Specs (September 3, 2026).
How to tell if you have this one
Check if you have Allopurinol Tablets USP, 300 mg, in a 500-count bottle. Look for NDC 0603-2116-28 and Lot Number CP0761501 with an expiration date of 12/16. The product was manufactured for Qualitest Pharmaceuticals in Huntsville, AL.
Brand
Qualitest Pharmaceuticals
Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and PR” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1405-2015 (July 20, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1405-2015 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.